Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 27;15(17):4290. doi: 10.3390/cancers15174290

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Mechanism of uptake of different radiopharmaceuticals in radioiodine-refractory differentiated thyroid cancer. Legend: FAP—fibroblast activation protein; GLUT—glucose transporter; SSTR—somatostatin receptors; [¹⁸F]FDG—2-[¹⁸F]fluoro-2-deoxy-D-glucose; [⁶⁸Ga]Ga-PSMA—[⁶⁸Ga]gallium-prostate-specific membrane antigen; [¹⁸F]F-PSMA—[¹⁸F]fluoro-prostate-specific membrane antigen; [⁶⁸Ga]Ga-DOTA-TATE—[⁶⁸Ga]Gallium-DOTA-Tyr³-octreotate; [⁶⁸Ga]Ga-DOTA-NOC—[⁶⁸Ga]Gallium-DOTA-NaI³-octreotide; [⁶⁸Ga]Ga-DOTA-TOC—[⁶⁸Ga]Gallium-DOTA-Tyr³-octreotide; [⁶⁸Ga]Ga-DOTA-FAPI- [⁶⁸Ga]Gallium-DOTA-fibroblast activation protein inhibitor.